New Delhi: The Drug Controller General of India has given permission to Indian pharmaceutical company Bharat Biotech to test for nasal cod medicine.
Sources said here on Friday that Drug Controller General of India has given permission to India Biotech to test for nasal cod medicine which will be given to adults as booster dose or supplemental dose.
According to sources, the drug will be given as a third dose to the recipients of CoveShield and Covacon Code.
Read Also : Google will invest 1 billion in a partnership with Airtel
Follow us on Google News Asia Times Now page for faster updates.
